Współczesna Onkologia

Full text

3/2026 vol. 30
Original paper

AARS2-mediated histone lactylation drives SLC7A11 expression to suppress ferroptosis in lung cancer

  1. Department of Thoracic Surgery, Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China

Contemp Oncol (Pozn) 2026; 30 (3): 277–289

Data publikacji online: 2026/11/09
Article file
AARS2-mediated.pdf
  1. Cai S, Zhang B, Huang C, Deng Y, Wang C, Yang Y, et al. CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway. Cancer Lett 2023; 579: 216465.
  2. Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S, et al. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct Target Ther 2020; 5: 51.
  3. Hsieh CH, Hsieh HC, Shih FS, Wang PW, Yang LX, Shieh DB, et al. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics 2021; 11: 7072-7091.
  4. Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 2023; 42: 83-98.
  5. Ma L, Chen C, Zhao C, Li T, Ma L, Jiang J, et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct Target Ther 2024; 9: 64.
  6. Tang X, Ding H, Liang M, Chen X, Yan Y, Wan N, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer 2021; 12: 1219-1230.
  7. Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med 2021; 11: e390.
  8. Guo Z, Tang Y, Wang S, Huang Y, Chi O, Xu K, et al. Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non-small cell lung cancer tumorigenesis. Biofactors 2024; 50: 592-607.
  9. He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, et al., Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep 2023; 42: 112033.
  10. Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature 2024; 634: 1229-1237.
  11. Liu L, Gao J, Liu X, Zhang F, Hu B, Zhang H, et al. AARS2 as a novel biomarker for prognosis and its molecular characterization in pan-cancer. Cancer Med 2023; 12: 21531-21544.
  12. Parra SP, Heckers SH, Wilcox WR, Mcknight CD, Jinnah HA, The emerging neurological spectrum of AARS2-associated disorders. Parkinsonism Relat Disord 2021; 93: 50-54.
  13. Zhang X, Li J, Zhang Y, Gao M, Peng T, Tian T, et al. AARS2-related leukodystrophy: a case report and literature review. Cerebellum 2023; 22: 59-69.
  14. Wei X, Li X, Hu S, Cheng J, Cai R. Regulation of ferroptosis in lung adenocarcinoma. Int J Mol Sci 2023; 24: 14614.
  15. Li P, Yu J, Huang F, Zhu YY, Chen DD, Zhang ZX, et al. SLC7A11-associated ferroptosis in acute injury diseases: mechanisms and strategies. Eur Rev Med Pharmacol Sci 2023; 27: 4386-4398.
  16. Wang D, Li X, Jiao D, Cai Y, Qian L, Shen Y, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J Hematol Oncol 2023; 16: 30.
  17. Xiong R, He R, Liu B, Jiang W, Wang B, Li N, et al. Ferroptosis: a new promising target for lung cancer therapy. Oxid Med Cell Longev 2021; 2021: 8457521.
  18. Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J, et al. Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11. Cancer Res 2021; 81: 5217-5229.
  19. Jiang J, Huang DL, Jiang Y, Hou J, Tian MY, Li J, et al. Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer. Front Oncol 2021; 11: 647559.
  20. Koppula PL, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 2021; 12: 599-620.
  21. Xie Y, Hu H, Liu M, Zhou T, Cheng X, Huang W, et al. The role and mechanism of histone lactylation in health and diseases. Front Genet 2022; 13: 949252.
  22. Zhang C, , Zhou L, Zhang M, Du Y, Li C, Ren H, et al., H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res 2024; 84: 3589-3601.
  23. Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu M, et al. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J Transl Med 2023; 21: 547.
  24. Yang J, , Zhou Y, Xie S, Wang J, Li Z, Chen L, et al. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res 2021; 40: 206.
  25. Shen L, Zhang J, Zheng Z, Yang F, Liu S, Wu Y, et al. PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer. Int J Biol Sci 2022; 18: 5459-5474.
  26. Yuan Y, Zhai Y, Chen J, Xu X, Wang H. Kaempferol ameliorates oxygen-glucose deprivation/reoxygenation-induced neuronal ferroptosis by activating Nrf2/SLC7A11/GPX4 axis. Biomolecules; 2021: 11: 923.
  27. Fan Y, Han J, Yang Y, Chen T. Novel mitochondrial alanyl-tRNA synthetase 2 (AARS2) heterozygous mutations in a Chinese patient with adult-onset leukoencephalopathy. BMC Neurol 2022; 22: 214.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees